The goal of this investigation is to determine the role of the blood/materials interaction in prosthetic arterial graft thrombosis. The relationship between baseline host platelet responsiveness, acute phase reactivity to the prosthetic graft and chronic reactivity to graft thrombosis and anastomotic hyperplasia will be determined. We have developed a dog model with a long prosthetic arterial graft (50.0 cm) designed for simple subcutaneous arterial blood sampling. We will simultaneously collect samples as blood enters the prosthetic artery and 50.0 cm distal in the conduit over extended time periods (months). This provides for a comprehensive study of events over time that occur in blood on a single pass through the conduit. The following blood components will be examined: 1) platelets; platelet count, mean platelet volume, platelet aggregation and degranulation studies, platelet survival studies, thromboxane B2 release, and transforming growth B1, 2) white blood cells; wbc count, differential, 3) complete blood count; RBC, MCV, hematocrit, 4) thrombin activity; fibrinopeptide A production, 5) plasmin activity, fibrin (ogen) degradation products. The grafts will be removed after eight months implantation and histologically examined using light, scanning and transmission electron microscopy. Pre-clotted knitted Dacron arterial grafts will be studied. The blood/materials interaction will be altered through the use of Ticlopidine and by chronic intra-arterial infusion of r-hirudin. This transformation will improve understanding of the mechanism of arterial graft thrombosis. It will provide a basis for selection of patients, modification of materials, and approaches to drug intervention.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
2R01HL021796-12A2
Application #
3336625
Study Section
Surgery and Bioengineering Study Section (SB)
Project Start
1987-07-01
Project End
1995-03-31
Budget Start
1992-04-06
Budget End
1993-03-31
Support Year
12
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Beth Israel Deaconess Medical Center
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02215
Nabzdyk, Christoph S; Pradhan-Nabzdyk, Leena; LoGerfo, Frank W (2017) RNAi therapy to the wall of arteries and veins: anatomical, physiologic, and pharmacological considerations. J Transl Med 15:164
Bodewes, Thomas C F; Johnson, Joel M; Auster, Michael et al. (2017) Intraluminal delivery of thrombospondin-2 small interfering RNA inhibits the vascular response to injury in a rat carotid balloon angioplasty model. FASEB J 31:109-119
Raof, Nurazhani A; Rajamani, Deepa; Chu, Hsun-Chieh et al. (2016) The effects of transfection reagent polyethyleneimine (PEI) and non-targeting control siRNAs on global gene expression in human aortic smooth muscle cells. BMC Genomics 17:20
Pradhan-Nabzdyk, Leena; Huang, Chenyu; LoGerfo, Frank W et al. (2014) Current siRNA targets in atherosclerosis and aortic aneurysm. Discov Med 17:233-46
Nabzdyk, Christoph S; Chun, Maggie C; Oliver-Allen, Hunter S et al. (2014) Gene silencing in human aortic smooth muscle cells induced by PEI-siRNA complexes released from dip-coated electrospun poly(ethylene terephthalate) grafts. Biomaterials 35:3071-9
Pradhan-Nabzdyk, Leena; Huang, Chenyu; LoGerfo, Frank W et al. (2014) Current siRNA targets in the prevention and treatment of intimal hyperplasia. Discov Med 18:125-32
McGillicuddy, Fiona C; Moll, Herwig P; Farouk, Samira et al. (2014) Translational studies of A20 in atherosclerosis and cardiovascular disease. Adv Exp Med Biol 809:83-101
da Silva, Cleide Gonçalves; Minussi, Darlan Conterno; Ferran, Christiane et al. (2014) A20 expressing tumors and anticancer drug resistance. Adv Exp Med Biol 809:65-81
Nabzdyk, Christoph S; Chun, Maggie; Pradhan Nabzdyk, Leena et al. (2012) Differential susceptibility of human primary aortic and coronary artery vascular cells to RNA interference. Biochem Biophys Res Commun 425:261-5
Bhasin, Manoj; Huang, Zhen; Pradhan-Nabzdyk, Leena et al. (2012) Temporal network based analysis of cell specific vein graft transcriptome defines key pathways and hub genes in implantation injury. PLoS One 7:e39123

Showing the most recent 10 out of 41 publications